NCT00231673 – A Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Topiramate on Electrophysiological Parameters in Subjects With Diabetic Peripheral Polyneuropathy Posted on April 8, 2020 by tsuperadmin -
NCT00210925 – A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Alcohol Dependence Posted on March 27, 2020 by tsuperadmin -
NCT00236613 – A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Dose-Response Study to Assess the Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity Posted on March 27, 2020 by tsuperadmin -
NCT00236860 – Double-Blind Parallel Comparison of Topiramate 400 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy Posted on March 26, 2020 by tsuperadmin -
NCT00236873 – Double-Blind Parallel Comparison of Topiramate 200 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy Posted on March 26, 2020 by tsuperadmin -
NCT00236730 – Double-Blind Parallel Comparison of Three Doses of Topiramate and Placebo in Refractory Partial Epilepsy Posted on March 26, 2020 by tsuperadmin -
NCT00236756 – A Double-Blind Trial of Topiramate in Subjects With Lennox-Gastaut Syndrome. Posted on March 26, 2020 by tsuperadmin -
NCT00236847 – Double-Blind, Parallel Comparison of Topiramate 300 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy Posted on March 26, 2020 by tsuperadmin -
NCT00236704 – Topiramate Clinical Trial in Primary Generalized Tonic-Clonic Seizures Posted on March 26, 2020 by tsuperadmin -
NCT00253175 – A Comparison Of The Efficacy And Safety Of Topamax® (Topiramate) Tablets Versus Placebo For The Prophylaxis Of Migraine Posted on March 26, 2020 by tsuperadmin -
The YODA Project